The adduct can interfere with copying by changing a nucleotide or distorting the DNA helix. If cellular machinery cannot copy past the lesion, replication may stall; if a polymerase copies across it inaccurately, the event can generate a characteristic mutation. Thus, the same experimental system can reveal both blocking and mutagenic consequences of DNA damage.
Nucleotide excision repair and translesion synthesis address the lesion in different ways. Nucleotide excision repair recognizes and processes damaged DNA, whereas translesion synthesis allows replication to proceed across a lesion. Tracking these responses in cells carrying the plasmid helps distinguish removal of the adduct from tolerance of it during copying, clarifying how each pathway contributes to the observed genetic outcome.
Because the plasmid carries a defined lesion, researchers can examine cellular responses to a known DNA alteration rather than relying only on damage produced broadly by an exposure. Following the same construct in living cells connects lesion recognition, repair processing, replication behavior, and mutation formation, making the relationship between a specific adduct and its genetic consequences easier to evaluate.
Researchers first use a circular plasmid carrying the defined DNA adduct, introduce it into cells, and then follow how the cell handles the lesion. Measurements can focus on repair processing, replication across the damaged site, or mutations associated with copying. This workflow links a chemically specified DNA change to a cellular response in a living genetic system.
They can show whether the lesion is recognized and processed, whether replication is blocked or continues through lesion bypass, and whether copying produces characteristic mutations. These outcomes address complementary questions: repair efficiency indicates how effectively cells remove or process damage, while bypass and mutation patterns indicate how the lesion affects replication and genome stability.
An adduct can serve as a defined molecular consequence of exposure to an environmental or therapeutic agent. Introducing the modified plasmid into cells allows researchers to examine how repair and replication pathways respond to that type of damage and whether characteristic mutations arise. The results help connect DNA lesion processing with broader questions about genome stability and chemical carcinogenesis.